S E Slater
Overview
Explore the profile of S E Slater including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slater S, Patel P, Viney R, Foster M, Porfiri E, James N, et al.
Ann R Coll Surg Engl
. 2014 Sep;
96(6):415-9.
PMID: 25198970
Introduction: Preliminary studies show that device assisted intravesical therapies appear more effective than passive diffusion intravesical therapy for the treatment of non-muscle invasive bladder cancer (NMIBC) in specific settings, and...
2.
Verma R, Bowen R, Slater S, Mihaimeed F, Jones J
Br Med Bull
. 2012 Aug;
103(1):129-45.
PMID: 22864058
Background: Breast cancer is a highly heterogeneous disease, but the stage at presentation significantly influences outcome. It is important to dissect the pathobiological and epidemiological factors that influence the stage...
3.
Foran J, Slater S, Norton A, Wilkes S, Hart I, Rohatiner A
Br J Haematol
. 1999 Sep;
106(3):713-6.
PMID: 10468862
A 31-year-old patient in remission of acute lymphoblastic leukaemia (ALL), receiving oral maintenance chemotherapy (6-mercaptopurine, methotrexate (MTX), cyclophosphamide), developed a monoclonal, Epstein-Barr virus (EBV)-related lymphoproliferative disorder (LPD). Treatment consisted of...
4.
Blystone S, Slater S, Williams M, Crow M, Brown E
J Cell Biol
. 1999 May;
145(4):889-97.
PMID: 10330414
Many cells express more than one integrin receptor for extracellular matrix, and in vivo these receptors may be simultaneously engaged. Ligation of one integrin may influence the behavior of others...
5.
Roach T, Slater S, White L, Zhang X, MAJERUS P, Brown E, et al.
Curr Biol
. 1998 Sep;
8(18):1035-8.
PMID: 9740804
The Src homology 2 domain phosphatase-1 (SHP-1) is a tyrosine phosphatase containing two amino-terminal SH2 domains and is expressed primarily by hematopoietic-derived cells [1]. The viable motheaten (Hcphme-v) mutant mice...
6.
Blystone S, Williams M, Slater S, Brown E
J Biol Chem
. 1997 Nov;
272(45):28757-61.
PMID: 9353346
Leukocytes and platelets require stimulation for optimal beta3 integrin receptor function, whereas beta3 function is constitutive in many other cells. The molecular mechanisms that enhance integrin function in stimulated hematopoietic...
7.
Slater S, MacCallum P, Birjandi F, Gibbons B, Lister T
Hematol Oncol
. 1992 May;
10(3-4):221-3.
PMID: 1398517
Diabetes insipidus (DI) is a rare complication of acute myelogenous leukemia (AML). Five of the six such cases described in the literature who had banded chromosomal studies performed had monosomy...
8.
Goodwin J, Jenner F, Slater S
J Physiol
. 1968 May;
196(2):112P-113P.
PMID: 5652856
No abstract available.